OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 31
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 14
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 14
Metformin role in Parkinson’s disease: a double-sword effect
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 975-991
Closed Access | Times Cited: 31
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 975-991
Closed Access | Times Cited: 31
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 26
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 26
The beneficial role of autophagy in multiple sclerosis: Yes or No?
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Autophagy (2023) Vol. 20, Iss. 2, pp. 259-274
Open Access | Times Cited: 25
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Autophagy (2023) Vol. 20, Iss. 2, pp. 259-274
Open Access | Times Cited: 25
The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2469-2480
Closed Access | Times Cited: 21
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2469-2480
Closed Access | Times Cited: 21
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 12
New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 11
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 11
Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 9
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 9
Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7092-7108
Open Access | Times Cited: 8
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7092-7108
Open Access | Times Cited: 8
Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration
Elena Gavilán, Rafael Medina-Guzman, Bazhena Bahatyrevich-Kharitonik, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 123-123
Open Access | Times Cited: 7
Elena Gavilán, Rafael Medina-Guzman, Bazhena Bahatyrevich-Kharitonik, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 123-123
Open Access | Times Cited: 7
Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
Andrei Surguchov, Fatemeh Nouri Emamzadeh, Mariya Titova, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 18
Andrei Surguchov, Fatemeh Nouri Emamzadeh, Mariya Titova, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 18
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Salwa H Zekry, et al.
Neuroscience (2025)
Closed Access
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Salwa H Zekry, et al.
Neuroscience (2025)
Closed Access
Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
Microglial Inflammatory Responses to SARS‐CoV‐2 Infection: A Comprehensive Review
Rajen Dey, Biswadev Bishayi
Cellular and Molecular Neurobiology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 13
Rajen Dey, Biswadev Bishayi
Cellular and Molecular Neurobiology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 13
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
The effects of cholesterol and statins on Parkinson’s neuropathology: a narrative review
Hayder M. Al‐kuraishy, Esraa H. Fahad, Salah Al‐Windy, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 917-925
Closed Access | Times Cited: 3
Hayder M. Al‐kuraishy, Esraa H. Fahad, Salah Al‐Windy, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 917-925
Closed Access | Times Cited: 3
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition
Jennifer Frontera, Alla Guekht, Ricardo Allegri, et al.
Journal of the Neurological Sciences (2023) Vol. 454, pp. 120827-120827
Closed Access | Times Cited: 9
Jennifer Frontera, Alla Guekht, Ricardo Allegri, et al.
Journal of the Neurological Sciences (2023) Vol. 454, pp. 120827-120827
Closed Access | Times Cited: 9
Viral amyloids: New opportunities for antiviral therapeutic strategies
Frank Gondelaud, Pierre‐Yves Lozach, Sonia Longhi
Current Opinion in Structural Biology (2023) Vol. 83, pp. 102706-102706
Open Access | Times Cited: 8
Frank Gondelaud, Pierre‐Yves Lozach, Sonia Longhi
Current Opinion in Structural Biology (2023) Vol. 83, pp. 102706-102706
Open Access | Times Cited: 8
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID‐19 infection
Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 2
Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 2
Calprotectin in Parkinsonian disease: Anticipation and dedication
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ayah Talal Zaidalkiani, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102143-102143
Closed Access | Times Cited: 7
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ayah Talal Zaidalkiani, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102143-102143
Closed Access | Times Cited: 7
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 7
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 7
Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Dopaminergic system and neurons: role in multiple neurological diseases
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 1
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 1
